- CA$1.40bn
- CA$2.97bn
- $3.12bn
- 72
- 65
- 72
- 79
Annual income statement for NFI, fiscal year end - December 29th, USD millions except per share, conversion factor applied.
2020 December 27th | 2022 January 2nd | C2023 December 31st | R2023 January 1st | 2024 December 29th | |
---|---|---|---|---|---|
Period Length: | 52 W | 53 W | 52 W | 52 W | 52 W |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 2,419 | 2,344 | 2,692 | 2,061 | 3,122 |
Cost of Revenue | |||||
Gross Profit | 153 | 187 | 221 | 49.1 | 349 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2,501 | 2,298 | 2,705 | 2,349 | 3,016 |
Operating Profit | -81.3 | 46 | -12.3 | -288 | 106 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -156 | -4.93 | -169 | -324 | -6.46 |
Provision for Income Taxes | |||||
Net Income After Taxes | -158 | -14.5 | -136 | -276 | -3.3 |
Net Income Before Extraordinary Items | |||||
Net Income | -158 | -14.5 | -136 | -276 | -3.3 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -158 | -14.5 | -136 | -276 | -3.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -2.28 | -0.6 | -1.51 | -2.55 | 0.054 |
Dividends per Share |